- Home
- UAL vs STE Comparison
UAL vs STE Comparison
Compare UAL & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UAL | STE |
|---|---|---|
| Founded | 1934 | 1985 |
| Country | United States | United States |
| Employees | 87000 | 3700 |
| Industry | Air Freight/Delivery Services | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.9B | 22.3B |
| IPO Year | 1995 | 2018 |
Fundamental Metrics
Financial Performance| Metric | UAL | STE |
|---|---|---|
| Price | $86.37 | $214.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 6 |
| Target Price | $132.81 | ★ $275.20 |
| AVG Volume (30 Days) | ★ 6.9M | 846.3K |
| Earning Date | 04-21-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.19% |
| EPS Growth | 7.94 | ★ 62.73 |
| EPS | ★ 10.20 | 5.69 |
| Revenue | ★ $37,736,000,000.00 | $5,459,515,000.00 |
| Revenue This Year | $9.22 | $9.88 |
| Revenue Next Year | $6.58 | $6.32 |
| P/E Ratio | ★ $8.48 | $37.42 |
| Revenue Growth | 3.23 | ★ 6.24 |
| 52 Week Low | $52.00 | $204.90 |
| 52 Week High | $119.21 | $269.44 |
Technical Indicators
Market Signals| Indicator | UAL | STE |
|---|---|---|
| Relative Strength Index (RSI) | 30.68 | 24.65 |
| Support Level | $71.55 | N/A |
| Resistance Level | $94.01 | $254.67 |
| Average True Range (ATR) | 5.12 | 5.90 |
| MACD | -2.10 | -3.20 |
| Stochastic Oscillator | 4.00 | 11.00 |
Price Performance
Historical ComparisonAbout UAL United Airlines Holdings Inc.
Chicago-based United Airlines is a major US network carrier with hubs in San Francisco, Chicago, Houston, Denver, Los Angeles, Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international and long-haul travel, especially across the Pacific, than its large US peers.
About STE STERIS plc (Ireland)
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.